EFTA00309574Set 9
2014-04-282p1,111w
cancer data at ASCO, potential in other tumours
and the data in combination with Avastin, if positive, have the potential to Bloomberg JPMA VOSSER
drive further upside ... 1Q14 call Roche James D Gordon
seemed more cautious than previously around the Avastin combo opportunity.
Beyond PD-LI , phase II ROMULUS data for the Anti-79b in NHL (ASCO ... ASCO, PD-LI potential in other tumours and the data in
combination with Avastin, if positive, have the potential to drive upside to PD-L I
forecasts but also
https://www.justice.gov/epstein/files/DataSet%209/EFTA00309574.pdf